NCT07662044: A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- State
- Under way
- Phase
- Phase 3
- People
- 800 planned
- Started
- 6 Jul 2026
- Primary completion
- 14 Jul 2028
- Arms
- Elecoglipron dose level 1 + dapagliflozin-matched placebo, Elecoglipron dose level 2 + dapagliflozin-matched placebo
- Results
- None posted
- 23 Jun 2026: Trial registered
- 6 Jul 2026: Trial started